• Profile
Close

Safety of high-dose vitamin D supplementation: Secondary analysis of a randomized controlled trial

Journal of Clinical Endocrinology & Metabolism Mar 18, 2020

Billington EO, Burt LA, Rose MS, et al. - In this investigation involving healthy adults (n = 373), aged 55 to 70 years, with serum 25-hydroxyvitamin D 30 to 125 nmol/L, experts aspired to explore if vitamin D doses up to 10,000 IU/day are well tolerated and safe. This investigation was carried out at the University of Calgary, Canada. Participants in the study were randomly assigned 1:1:1 to vitamin D3 400, 40,000, or 10,000 IU/day. Calcium supplementation was started if the dietary calcium intake was less than 1,200 mg/day. Using incident rate differences and logistic regression, between-group differences in adverse events were examined. According to results, serum calcium, creatinine, and 24-hour urine calcium excretion did not vary between treatments. Vitamin D supplementation's safety profile is comparable for the 400, 4,000, and 10,000 IU/day doses. Hypercalciuria was common and occurred more often at higher doses. At higher doses, hypercalcemia occurred more frequently but was rare, mild, and transient.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay